Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial‐mesenchymal transition in Panc‐1 and MiaPaCa‐2 pancreatic cancer cells-Reference-Cited by-同舟云学术

Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial‐mesenchymal transition in Panc‐1 and MiaPaCa‐2 pancreatic cancer cells

Published:2019-07 Issue:1 Volume:121 Page:508-523
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Rencuzogulları Ozge¹²^ORCID,Yerlikaya Pınar Obakan¹^ORCID,Gürkan Ajda Çoker¹^ORCID,Arısan Elif Damla¹^ORCID,Telci Dilek²^ORCID

Affiliation:

1. Department of Molecular Biology and Genetics, Science and Literature Faculty Istanbul Kultur University Istanbul Turkey

2. Department of Genetics and Bioengineering, Faculty of Engineering Yeditepe University Istanbul Turkey

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.29249

Reference50 articles.

1. Cancer statistics, 2017

2. Analysis of mortality rates for pancreatic cancer across the world

3. Oncogenic KRAS Activates Hedgehog Signaling Pathway in Pancreatic Cancer Cells

4. PI3K-Akt pathway: Its functions and alterations in human cancer

5. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells;Cancers;2024-07-30

2. Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies;Cancer Letters;2024-04

3. Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives;World Journal of Gastrointestinal Oncology;2023-06-15

4. Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21;European Journal of Cell Biology;2023-06

5. Recent advances in targeted therapy for pancreatic adenocarcinoma;World Journal of Gastrointestinal Oncology;2023-04-15